Keytruda scored an approval in lung cancer, but its narrow label will likely have it playing second fiddle.
Keytruda approved in non-small cell lung cancer; Enbrel biosimilar inches closer to approval; study finds no link between autism and vaccines
Test your knowledge in this week's edition of the MM&M Weekly News Quiz.
Hillary Clinton proposes stricter regulation of opioid painkillers; the FTC argues drugmakers make slight changes to drugs to prevent generics; MannKind layoffs continue
The annual MM&M Awards ceremony, held Thursday night in New York City, showcases the best in healthcare marketing, communications and media.
Ghg's financial stake in the company highlights the growing interest among pharma marketers to engage physicians through EHR platforms.
The FDA approves Opdivo/Yervoy combination to treat melanoma; BioMarin acquires global rights to Kuvan; Allergan's Juvederm receives marketing approval for lip augmentation
An analysis conducted by J&J executives found that 58% of FDA warning letters and untitled letters over the last two years omitted risk information.
A GSK manager said that bringing digital devices to clinical trials could lower the cost of bringing medicines to patients.
Teva exec says pharma needs to pay attention to its reputation; academics who serve on boards of healthcare companies face potential conflicts of interest; WHO recommendation will boost number of people taking anti-retrovirals